NCT01095822View on ClinicalTrials.gov

Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

March 31, 2011

Conditions
Diabetes Mellitus
Interventions
DRUG

Aliskiren + Valsartan

Comparison of combination (aliskiren + valsartan) therapy versus valsartan alone on hemostatic indices

Trial Locations (1)

21215

Dr. Pokov's Polyclinic. 6821 Reisterstown Road Suite 206, Baltimore

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

HeartDrug Research LLC

OTHER